Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
06/2004
06/10/2004CA2511762A1 Improved process for the preparation of 1,3-substituted indenes
06/10/2004CA2507458A1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
06/10/2004CA2506794A1 Method for producing an aliphatic dialdehyde monoacetal
06/09/2004EP1426379A1 Transition metal complex,catalyst for olefin polymerization, and process for producing olefin polymer with the same
06/09/2004EP1426369A1 7-Substituted fused ring tetracycline compounds
06/09/2004EP1426048A2 Treating hypertriglyceridemia with RXR agonists in combination with a PPARgamma agonist
06/09/2004DE10255647A1 Verfahren zur Gewinnung eines aliphatischen Dialdehyd-Monoacetals A process for recovering an aliphatic dialdehyde monoacetal
06/09/2004CN1503781A Process for the preparatino of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
06/09/2004CN1503774A Carboxylic acid derivative and thereof
06/09/2004CN1502598A Process for synthesis of cis-1-2-4-(6-methoxy-2-phenyl-1,2,3,4- tetrahydronaphthalen-1-yl)-phenoxy-ethyl-pyrrolidine
06/09/2004CN1502597A Process for synthesis of cis-1-2-4-(6-methoxy-2-phenyl-1,2,3,4- tetrahydronaphthalen-1)-phenoxy- ethyl-pyrrolidine
06/09/2004CN1152679C Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agent
06/09/2004CN1152675C IL-8 receptor antagonists
06/08/2004US6747174 Processes for the preparation of fluorinated acyl fluorides and fluorinated vinyl ethers
06/08/2004US6747143 Methods for polymer synthesis
06/08/2004US6747109 High hydrolytic stability; no variations in half-life; producing polyvinylidene fluoride-based polymers
06/08/2004US6747031 N-heterocyclic derivatives as NOS inhibitors
06/08/2004US6747027 Selectively inhibits in vitro activity of human matrix metalloprotease-13 over in vitro activity of human matrix metalloprotease-1
06/08/2004US6747024 Inhibiting calpain and/or reactive oxygen species in warm-blooded animals
06/03/2004WO2004046162A2 Non-steroidal fxr agonists
06/03/2004WO2004046090A2 Aryl ureido derivatives and their medical use
06/03/2004US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
06/03/2004US20040106792 Biphenyl compound
06/03/2004US20040106611 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
06/03/2004US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent
06/03/2004CA2502705A1 Aryl ureido derivatives and their medical use
06/02/2004EP1423377A1 Method for producing glycerol carbonate
06/02/2004EP1423356A2 Novel aminobenzoephenones
06/02/2004CN1152036C Method for preparing platinum (II) complexes
06/02/2004CN1152007C Pesticides
06/02/2004CN1151836C Compounds and compositions for delivering active agents
06/01/2004US6743914 Using tertiary amine catalyst
06/01/2004US6743910 Stereoselective synthesis of nucleoside analogues
06/01/2004US6743808 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) tetrahydropyridines or piperazines
06/01/2004US6743566 Cyclic acetal compound, polymer, resist composition and patterning process
05/2004
05/27/2004WO2004026816A8 Aromatic liver x-receptor modulators
05/27/2004US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease
05/27/2004US20040102418 Compounds for the treatment of inflammatory disorders
05/26/2004EP1421634A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
05/26/2004EP1421073A2 Process for making of a compound containing cyclic and linear carbonate groups
05/26/2004EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
05/26/2004EP1421061A1 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
05/26/2004EP1420644A1 Substituted propargylamines
05/26/2004EP1185523B1 Vinyl monomer, support matrix and its preparation
05/26/2004EP0915819B1 Illudin analogs useful as antitumor agents
05/26/2004CN1151145C Double-function catalyst for synthesizing cyclic carbonate and methyl carbonate
05/25/2004US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury.
05/21/2004WO2004041836A1 Continuous process for the preparation of fructopyranose sulfamate derivatives
05/21/2004WO2004041823A1 Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
05/21/2004WO2004041805A1 NEW PROCESS FOR THE PREPARATION OF RACEMIC ([2S[2R*[R[R*]]]] and ([2R[2S*[S[S*]]]]-(±)- α,α' -[imino-bis(methylene)]bis[6-fluoro­chroman-2-methanol] AND ITS PURE [2S[2R*[R[R*]&
05/21/2004WO2004041787A1 Process for producing quinolinecarbaldehyde
05/21/2004WO2004041264A1 2-oxo-ethanesulfonamide derivates
05/21/2004WO2004041201A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
05/21/2004CA2505239A1 Process for producing quinolinecarbaldehyde
05/21/2004CA2504344A1 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
05/21/2004CA2504039A1 Continuous process for the preparation of fructopyranose sulfamate derivatives
05/21/2004CA2502477A1 Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
05/20/2004US20040097745 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
05/20/2004US20040097547 For therapy of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
05/20/2004US20040097487 To inhibits matrix metalloprotease activity
05/20/2004US20040097402 Therapy for infections; bactericides; synergistic mixtures
05/19/2004EP1419125A1 Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids
05/19/2004EP1418923A1 Anti-bacterial agents based upon oxoanion binding
05/19/2004EP1418879A1 Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
05/19/2004EP1027342B1 Cyclopentene derivatives useful as antagonists of the motilin receptor
05/19/2004CN1498205A Aryl and biaryl compounds having MCH modulatory activity
05/19/2004CN1496981A Cycloamine derivative and its use as medicine
05/19/2004CN1150181C Substituted benzopyran analogs for treatment of inflammation
05/18/2004US6737425 N,N-substituted cyclic amine derivatives
05/18/2004US6737415 Anti-bacterial agents based upon oxoanion binding
05/13/2004WO2002102804A8 New use of specific cyclolignans
05/13/2004US20040092598 Antiproliferative agnets; anticancer agents; skin disorders
05/13/2004US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme
05/12/2004EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor
05/12/2004EP1097128B1 Imidamide derivatives
05/11/2004US6734203 Fused imidazolium derivatives
05/06/2004WO2004037806A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
05/06/2004WO2004013119B1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004US20040087806 Processes for preparing 1,3-dioxolane nucleosides
05/06/2004US20040087650 Inhibitors of IMPDH enzyme
05/06/2004US20040087600 Amino-substituted dihydropyrimido[4,5-D]pyrimidinone derivatives
05/06/2004US20040087585 Peptide deformylase inhibitors
05/06/2004EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
05/06/2004EP1307441B1 1,3-dioxolanes with antitussive activity
05/06/2004EP0968182B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/06/2004EP0960106B1 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
05/06/2004EP0915825B1 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
05/06/2004CA2503452A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
05/05/2004CN1494424A IL-8 receptor antagonists
05/04/2004US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants
05/04/2004US6730669 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
04/2004
04/29/2004WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/29/2004WO2004035540A1 Malonic acid monoesters and process for producing the same
04/29/2004WO2004035525A1 Inhibitors of histone deacetylase
04/29/2004WO2003086282A3 Nitric oxide donors, compositions and methods of use
04/29/2004WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
04/29/2004US20040083447 1-Phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands
04/29/2004US20040082820 Hydrogen transfer reduction; useful as intermediate for production of pharmaceuticals/agricultural chemicals
04/29/2004US20040082795 Asymmetric catalytic hydrogenation process for preparation of chiral cyclic beta-aminoesters
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 183